ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01777243
Recruitment Status : Completed
First Posted : January 28, 2013
Last Update Posted : May 9, 2017
Sponsor:
Collaborators:
Imperial College London
Heart Hospital
Royal Free Hospital NHS Foundation Trust
Quintiles, Inc.
Information provided by (Responsible Party):
GlaxoSmithKline